IGC PHARMA, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Amount
IGC PHARMA, INC. (IGC) reported Effective Income Tax Rate Reconciliation, Tax Credit, Amount of $262.00 thousand for the 9-month period ending 2025-12-31, per its 10-KT filed 2026-03-18.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCredits · last filed 2026-03-18
- IGC PHARMA, INC. effective income tax rate reconciliation, tax credit, amount for the quarter ending 2025-03-31 was $194.00K.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 3 month | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 9 month |
|---|---|---|
| 2025-12-31 | $262.00K 10-KT · filed 2026-03-18 | |
| 2025-03-31 | $194.00K 10-K · filed 2025-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |